KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Gross Profit (2020 - 2025)

Vir Biotechnology's Gross Profit history spans 6 years, with the latest figure at $1.2 million for Q2 2025.

  • For Q2 2025, Gross Profit fell 60.21% year-over-year to $1.2 million; the TTM value through Jun 2025 reached $18.3 million, down 75.08%, while the annual FY2025 figure was $68.5 million, 6.58% down from the prior year.
  • Gross Profit for Q2 2025 was $1.2 million at Vir Biotechnology, down from $3.0 million in the prior quarter.
  • Across five years, Gross Profit topped out at $1.1 billion in Q1 2022 and bottomed at $1.2 million in Q2 2025.
  • The 5-year median for Gross Profit is $14.3 million (2022), against an average of $152.0 million.
  • The largest annual shift saw Gross Profit soared 57709.21% in 2022 before it plummeted 99.26% in 2023.
  • A 5-year view of Gross Profit shows it stood at $764.6 million in 2021, then crashed by 94.32% to $43.4 million in 2022, then crashed by 63.17% to $16.0 million in 2023, then fell by 26.89% to $11.7 million in 2024, then crashed by 89.71% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for VIR's Gross Profit are $1.2 million (Q2 2025), $3.0 million (Q1 2025), and $11.7 million (Q4 2024).